Context Therapeutics Correlations

CNTX Stock  USD 0.77  0  0.26%   
The current 90-days correlation between Context Therapeutics and Acumen Pharmaceuticals is 0.33 (i.e., Weak diversification). The correlation of Context Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Context Therapeutics Correlation With Market

Weak diversification

The correlation between Context Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Context Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.

Moving together with Context Stock

  0.69DSGN Design TherapeuticsPairCorr
  0.8EYEN EyenoviaPairCorr
  0.88CGC Canopy Growth CorpPairCorr
  0.62MRK Merck CompanyPairCorr
  0.65INBX Inhibrx Symbol ChangePairCorr
  0.9ISPC iSpecimenPairCorr
  0.61ITOS Iteos TherapeuticsPairCorr
  0.71LFCR Lifecore BiomedicalPairCorr
  0.84MREO Mereo BioPharma GroupPairCorr
  0.82ANNX Annexon Earnings Call This WeekPairCorr
  0.79ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.68BLUE Bluebird bio Earnings Call This WeekPairCorr
  0.79TLRY Tilray IncPairCorr
  0.8CLDX Celldex TherapeuticsPairCorr
  0.87CRNX Crinetics PharmaceuticalsPairCorr
  0.8CRVS Corvus PharmaceuticalsPairCorr

Moving against Context Stock

  0.4OPT OptheaPairCorr
  0.83NVRO Nevro CorpPairCorr
  0.82FNA Paragon 28PairCorr
  0.74LUCD Lucid DiagnosticsPairCorr
  0.73CPIX Cumberland PharmaceuticalsPairCorr
  0.7NYXH NyxoahPairCorr
  0.68CMRX ChimerixPairCorr
  0.53CYTH Cyclo TherapeuticsPairCorr
  0.51INMD InModePairCorr
  0.49KIDS Orthopediatrics CorpPairCorr
  0.49LUNG Pulmonx CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ABOSTERN
INZYTERN
SPROABOS
CHRSSPRO
SPROTERN
CHRSTERN
  
High negative correlations   
NLTXGRCL
NLTXCHRS
GRCLCHRS
NLTXBOLT
GRCLBOLT
NLTXSPRO

Risk-Adjusted Indicators

There is a big difference between Context Stock performing well and Context Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Context Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TERN  2.99 (0.99) 0.00 (1.29) 0.00 
 4.94 
 19.13 
AMLX  3.72 (0.05) 0.00 (0.11) 0.00 
 7.20 
 21.45 
ABOS  2.97 (0.69) 0.00 (0.63) 0.00 
 6.57 
 19.77 
INZY  4.06 (1.42) 0.00 (0.90) 0.00 
 6.82 
 36.29 
XFOR  6.40 (0.54) 0.00 (1.69) 0.00 
 11.67 
 68.45 
SPRO  2.57 (0.56) 0.00  3.53  0.00 
 4.85 
 21.98 
BOLT  2.62 (0.22) 0.00 (1.22) 0.00 
 5.08 
 17.46 
CHRS  4.02 (0.81) 0.00  1.65  0.00 
 7.48 
 31.16 
GRCL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NLTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Context Therapeutics Corporate Management

Alex EsqChief SecretaryProfile
Martin LehrPresident, CoFounderProfile
Christopher MBASenior OperationsProfile
Tarek MDChief OfficerProfile
Elizabeth CPAControllerProfile
Jennifer MinaiAzaryCFO TreasurerProfile
Claudio MDChief OfficerProfile